RDY Neutral Sentiment Score: 55/100
Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co
Wednesday, January 31, 2024 1 min read
Key Takeaway: Dr. Reddy's Laboratories announced the audio recording of its earnings call for the quarter and nine months ended December 31, 2023, which was conducted on January 30, 2024. This announcement complies with Regulation 30 of the Securities and Exchange Board of India relating to listing obligations and disclosure requirements. The recording provides insights into the company's financial performance and strategic direction for investors and stakeholders. A link to the audio recording has been made available for public access.
Full Press Release Details
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Audio Recordings of the Earnings call conducted on January
Pursuant to Regulation 30 of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of the audio recordings
of the Earnings call for the quarter and nine months ended December 31, 2023, conducted on January 30, 2024.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer &